We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLNK icon
2476
Blink Charging
BLNK
$79.5M
$0 ﹤0.01%
20
– –
BLX icon
2477
Bladex Inc
BLX
$2.23B
$0 ﹤0.01%
7
– –
BNED icon
2478
Barnes & Noble Education
BNED
$445M
$0 ﹤0.01%
1
– –
BRF icon
2479
VanEck Brazil Small-Cap ETF
BRF
$21.8M
– –
-1,000
Closed -$23
BTO
2480
John Hancock Financial Opportunities Fund
BTO
$805M
– –
-1,000
Closed -$32
BUSE icon
2481
First Busey Corp
BUSE
$2.52B
$0 ﹤0.01%
36
– –
BBBY
2482
Bed Bath & Beyond
BBBY
$512M
$0 ﹤0.01%
19
– –
CARS icon
2483
Cars.com
CARS
$660M
$0 ﹤0.01%
1
– –
CCM
2484
Concord Medical Services
CCM
$19.6M
$0 ﹤0.01%
30
– –
CDXS icon
2485
Codexis
CDXS
$141M
$0 ﹤0.01%
52
-97
-65% -$1.44K
CHGG icon
2486
Chegg
CHGG
$110M
$0 ﹤0.01%
14
– –
CHRS icon
2487
Coherus Oncology
CHRS
$225M
$0 ﹤0.01%
31
– –
CHWY icon
2488
Chewy
CHWY
$8.93B
– –
-375
Closed -$9
CIM
2489
Chimera Investment
CIM
$1.05B
– –
-360
Closed -$21
CLLS
2490
Cellectis
CLLS
$291M
– –
-50
Closed –
CODI icon
2491
Compass Diversified
CODI
$755M
– –
-32
Closed –
CRBP icon
2492
Corbus Pharmaceuticals
CRBP
$168M
$0 ﹤0.01%
5
– –
CRNC icon
2493
Cerence
CRNC
$375M
$0 ﹤0.01%
+17
New +$279
CRON
2494
Cronos Group
CRON
$1.07B
– –
-975
Closed -$8
CVI icon
2495
CVR Energy
CVI
$3.43B
– –
-13
Closed –
CYCN icon
2496
Cyclerion Therapeutics
CYCN
$15.2M
$0 ﹤0.01%
10
– –
CYH icon
2497
Community Health Systems
CYH
$383M
$0 ﹤0.01%
188
– –
DDOG icon
2498
Datadog
DDOG
$89.7B
– –
-660
Closed -$22
DHX icon
2499
DHI Group
DHX
$164M
$0 ﹤0.01%
134
– –
DIM icon
2500
WisdomTree International MidCap Dividend Fund
DIM
$165M
– –
-5
Closed –
98 99
100
101 102

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.